On the other hand, their pleiotropic actions, frequent involvement of the central nervous system, and context-dependent effects have historically rendered them unattractive as therapeutic targets
Get Your Case Evaluated: Free Consultation Whether you took Ozempic, Wegovy, Mounjaro, Zepbound , or another GLP-1 medication, if you developed serious complications, you may be entitled to significant compensation
Vaccaro, C., Zhou, J., Ober, R
In their most recent earnings reported in early August, Eli Lilly said Mounjaro and Zepbound brought in a combined $8.6 billion in Q2, and Novo Nordisk reported Ozempic and Wegovy brought in a combined $8 billion for the quarter